Drug page
Retatrutide
Retatrutide is an injectable agonist at GIP, GLP-1 and glucagon receptors. This page gathers every report that discusses it.
Reports
Reports will appear here as new research is published.
Page updated 10 October 2026.
Today's Rounds, in your inbox at 8am
The day's reports each morning, and Weekend Rounds on Saturday. Free, no advertising.